Holen Sie sich die Stockscreener-App
83.28
0.99%
0.82
Handel nachbörslich:
83.32
0.04
+0.05%
Schlusskurs vom Vortag:
$82.46
Offen:
$82.74
24-Stunden-Volumen:
195.60K
Relative Volume:
0.86
Marktkapitalisierung:
$1.85B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
45.51
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
+1.45%
1M Leistung:
+0.56%
6M Leistung:
-18.81%
1J Leistung:
+9.28%
1-Tages-Spanne:
$82.33
$84.18
1-Wochen-Bereich:
$80.03
$84.18
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
83.28 | 1.85B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
563.95 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
93.25 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
247.65 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.76 | 16.11B | 3.93B | 415.40M | 384.70M | 2.06 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Ex-Dividend Reminder: Select Medical Holdings, LeMaitre Vascular and Selective Insurance Group - Nasdaq
Trading (LMAT) With Integrated Risk Controls - news.stocktradersdaily.com
Corton Capital Inc. Makes New Investment in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Investor Network: LeMaitre Vascular, Inc. to Host Earnings Call - ACCESS Newswire
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Up 4.2% After Dividend Announcement - MarketBeat
Tudor Investment Corp ET AL Purchases 20,597 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Comerica Bank - MarketBeat
Susquehanna Fundamental Investments LLC Buys Shares of 3,809 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Dimensional Fund Advisors LP Has $50.90 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by First Trust Advisors LP - MarketBeat
Tower Research Capital LLC TRC Acquires 3,538 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Shares Down 5.4% After Earnings Miss - MarketBeat
Elutia Inc. Ends Distribution Agreement with LeMaitre - TipRanks
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - simplywall.st
LeMaitre Vascular (NASDAQ:LMAT) Shares Up 4.2% After Dividend Announcement - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year LowShould You Sell? - MarketBeat
Monashee Investment Management LLC Takes Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Voya Investment Management LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Q1 2025 Financial Results - ADVFN
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference | LMAT Stock News - GuruFocus
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference - The Manila Times
LeMaitre President Sets Stage for Major Healthcare Conference Presentation: Key Updates Expected - Stock Titan
Nebula Research & Development LLC Grows Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Lemaitre Vascular (LMAT) Receives a Hold from KeyBanc - The Globe and Mail
LeMaitre raises 2025 sales guidance to $245M amid strong Q1 growth and international expansion - MSN
Long Term Trading Analysis for (LMAT) - news.stocktradersdaily.com
LeMaitre Vascular, Inc. to Host Earnings Call - ACCESS Newswire
Why LeMaitre (LMAT) Shares Are Sliding Today - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
LeMaitre Vascular Reports Strong Q1 2025 Growth - TipRanks
LeMaitre Vascular Q1 2025 Earnings Call Transcript - MarketBeat
LeMaitre: Q1 Earnings Snapshot - MySA
Earnings call transcript: LeMaitre Vascular Q1 2025 reports solid growth, stock dips - Investing.com India
LeMaitre (LMAT) Surpasses Q1 Revenue Expectations and Raises Fut - GuruFocus
LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales - Yahoo Finance
LeMaitre (LMAT) Surpasses Q1 Revenue Expectations and Raises Future Sales Guidance | LMAT Stock News - GuruFocus
LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates - Yahoo Finance
LeMaitre Vascular Inc Reports Q1 2025 Earnings: Revenue Surpasse - GuruFocus
Earnings Flash (LMAT) LeMaitre Vascular Q1 EPS $0.48 vs. FactSet Est $0.50 - marketscreener.com
LeMaitre Q1 2025 Financial Results | LMAT Stock News - GuruFocus
(LMAT) Lemaitre Vascular Sees Fiscal Year 2025 Revenue $242M$249M - marketscreener.com
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):